Macquarie Group’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,207
| Closed | -$273 | – | 1784 |
|
|
2024
Q4 | $273 | Buy |
+16,207
| New | +$273 | ﹤0.01% | 1612 |
|
|
2024
Q2 | – | Sell |
-160,000
| Closed | -$2.37M | – | 2090 |
|
|
2024
Q1 | $2.37M | Hold |
160,000
| – | – | ﹤0.01% | 1173 |
|
|
2023
Q4 | $2.32M | Hold |
160,000
| – | – | ﹤0.01% | 1178 |
|
|
2023
Q3 | $1.73M | Hold |
160,000
| – | – | ﹤0.01% | 1208 |
|
|
2023
Q2 | $2.06M | Hold |
160,000
| – | – | ﹤0.01% | 1175 |
|
|
2023
Q1 | $2.11M | Hold |
160,000
| – | – | ﹤0.01% | 1148 |
|
|
2022
Q4 | $2.4M | Hold |
160,000
| – | – | ﹤0.01% | 1154 |
|
|
2022
Q3 | $1.89M | Sell |
160,000
-325
| -0.2% | -$3.84K | ﹤0.01% | 1248 |
|
|
2022
Q2 | $1.81M | Hold |
160,325
| – | – | ﹤0.01% | 1329 |
|
|
2022
Q1 | $4.79K | Hold |
160,325
| – | – | ﹤0.01% | 1126 |
|
|
2021
Q4 | $4.25M | Hold |
160,325
| – | – | ﹤0.01% | 1155 |
|
|
2021
Q3 | $5.82M | Hold |
160,325
| – | – | 0.01% | 1069 |
|
|
2021
Q2 | $6.96M | Hold |
160,325
| – | – | 0.01% | 1034 |
|
|
2021
Q1 | $5.48M | Sell |
160,325
-154
| -0.1% | -$5.27K | 0.01% | 888 |
|
|
2020
Q4 | $5.62M | Hold |
160,479
| – | – | 0.01% | 857 |
|
|
2020
Q3 | $3.85M | Hold |
160,479
| – | – | 0.01% | 887 |
|
|
2020
Q2 | $2.94M | Buy |
160,479
+479
| +0.3% | +$8.77K | 0.01% | 913 |
|
|
2020
Q1 | $2.5M | Hold |
160,000
| – | – | 0.01% | 866 |
|
|
2019
Q4 | $3.42M | Hold |
160,000
| – | – | ﹤0.01% | 898 |
|
|
2019
Q3 | $2.99M | Hold |
160,000
| – | – | 0.01% | 905 |
|
|
2019
Q2 | $4.18M | Hold |
160,000
| – | – | 0.01% | 820 |
|
|
2019
Q1 | $4.11M | Hold |
160,000
| – | – | 0.01% | 828 |
|
|
2018
Q4 | $3.68M | Hold |
160,000
| – | – | 0.01% | 825 |
|
|
2018
Q3 | $5.14M | Hold |
160,000
| – | – | 0.01% | 781 |
|
|
2018
Q2 | $4.53M | Buy |
160,000
+70,000
| +78% | +$1.98M | 0.01% | 798 |
|
|
2018
Q1 | $3.19M | Buy |
90,000
+11,591
| +15% | +$410K | 0.01% | 863 |
|
|
2017
Q4 | $3.04M | Buy |
78,409
+5,000
| +7% | +$194K | 0.01% | 909 |
|
|
2017
Q3 | $1.87M | Buy |
73,409
+9,909
| +16% | +$252K | ﹤0.01% | 1007 |
|
|
2017
Q2 | $1.73M | Buy |
63,500
+10,279
| +19% | +$281K | ﹤0.01% | 1009 |
|
|
2017
Q1 | $1.76M | Buy |
+53,221
| New | +$1.76M | ﹤0.01% | 1005 |
|